Supporting Pharma Sales’ Journey Towards Greater Virtualization
The COVID-19 pandemic has forced many businesses to rethink how they reach their customers—and ...
Moving Toward an Agile KAM Future
Physical access has been a growing challenge in life sciences as the number of ...
Q&A with Frank Jaeger, Chief Commercial Officer, Clarus Therapeutics
In March 2019, Clarus Therapeutics got exciting news. JATENZO, the first and only oral ...
Four Biggest Challenges Facing Medical Device Marketers
Medical device marketing teams are facing unprecedented times as we roll into the back ...
Fight the Contagion with Contagion—Maximizing Reach Through Better Targeting
“eDetailing. Zoom lunches. Provide empathy and support for the staff. Be there…virtually. Don’t be ...
Innovative New Commercial Approaches for CAR T-cell Therapies
A promising gene immunotherapy, CAR T-cell therapy, has emerged as a new, cutting-edge treatment ...
Considering AI? 3 Ways to Set Your Commercial Team Up for Success
Artificial Intelligence (AI) is rapidly becoming pervasive in enterprise applications and embedded within specific ...
How IoT is Transforming the Pharma to Physician Relationship
In today’s word of global pandemics, tightening restrictions, and shrinking calendars, pharmaceutical companies face ...
Veeva Introduces New Remote Drug Sampling Capabilities
Veeva Systems already made remote meetings between physicians and reps easier for life sciences ...
The Next Chapter for Digital Therapeutics
Imagine you are a primary care physician (PCP) in a mid-sized Midwestern city. Over ...
How Medical Device Sales Reps Can Unlock Additional Revenue
Today’s medical sales environment is rapidly evolving. Trust and credibility are invaluable, but it’s ...
Underuse of Advanced Analytics Hurts Emerging Pharma Companies—Except When it Comes to Seeing No-See Physicians
Are “no-see” physicians actually as hard for reps to get into see as the ...
With Strict Compliance, Can There be Flexibility in Pharma Presentations?
Chances are you just read that headline and thought to yourself, “No. There is ...
- 1
- 2